Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (171-180 of 600) with videos related to

Pageof 60
Sort By:
BMC Infectious Diseases|November 4, 2011
Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseasesGuillaume Geri, Sabrina Dadoun, Tach Bui, et al.
The Journal of Rheumatology|August 17, 2013
Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup studyAnne Durnez, Simon Paternotte, Jacques Fechtenbaum, et al.
Clinical and Experimental Rheumatology|February 5, 2016
Prevalence and clinical characteristics of psoriasis in spondyloarthritis: a descriptive analysis of 275 patientsFanny Roure, Muriel Elhai, Vincent Burki, et al.
RMD Open|September 12, 2022
Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA studyDiego Benavent, Dafne Capelusnik, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|September 26, 2025
Global patterns and determinants of diagnostic delay in spondyloarthritis: insights from the ASAS-PerSpA international studyMaroun Aoun, Sherif M Gamal, Ihsane Hmamouchi, et al.
Joint Bone Spine|March 6, 2007
Practice patterns in outpatient rheumatology: a pilot evaluation of medical file contentJacques Fechtenbaum, France Lecoq d'André, Henri Nataf, et al.
The Journal of Rheumatology|September 10, 2009
OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugsMaxime Dougados, Gillian Hawker, Stefan Lohmander, et al.
The Journal of Rheumatology|November 3, 2011
Treatment of osteoarthritis with continuous versus intermittent celecoxibVibeke Strand, Lee S Simon, Maxime Dougados, et al.
Clinical and Experimental Rheumatology|July 10, 2014
Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended studyRene Westhovens, Joel M Kremer, Paul Emery, et al.
Rheumatology (Oxford, England)|March 18, 2019
Measuring spinal mobility in early axial spondyloarthritis: does it matter?Mary Lucy Marques, Sofia Ramiro, Philippe Goupille, et al.
Pageof 60

Showing results (171-180 of 600) with videos related to

Sort By:
Pageof 60
BMC Infectious Diseases|November 4, 2011
Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseasesGuillaume Geri, Sabrina Dadoun, Tach Bui, et al.
The Journal of Rheumatology|August 17, 2013
Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup studyAnne Durnez, Simon Paternotte, Jacques Fechtenbaum, et al.
Clinical and Experimental Rheumatology|February 5, 2016
Prevalence and clinical characteristics of psoriasis in spondyloarthritis: a descriptive analysis of 275 patientsFanny Roure, Muriel Elhai, Vincent Burki, et al.
RMD Open|September 12, 2022
Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA studyDiego Benavent, Dafne Capelusnik, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|September 26, 2025
Global patterns and determinants of diagnostic delay in spondyloarthritis: insights from the ASAS-PerSpA international studyMaroun Aoun, Sherif M Gamal, Ihsane Hmamouchi, et al.
Joint Bone Spine|March 6, 2007
Practice patterns in outpatient rheumatology: a pilot evaluation of medical file contentJacques Fechtenbaum, France Lecoq d'André, Henri Nataf, et al.
The Journal of Rheumatology|September 10, 2009
OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugsMaxime Dougados, Gillian Hawker, Stefan Lohmander, et al.
The Journal of Rheumatology|November 3, 2011
Treatment of osteoarthritis with continuous versus intermittent celecoxibVibeke Strand, Lee S Simon, Maxime Dougados, et al.
Clinical and Experimental Rheumatology|July 10, 2014
Long-term safety and efficacy of abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: a 7-year extended studyRene Westhovens, Joel M Kremer, Paul Emery, et al.
Rheumatology (Oxford, England)|March 18, 2019
Measuring spinal mobility in early axial spondyloarthritis: does it matter?Mary Lucy Marques, Sofia Ramiro, Philippe Goupille, et al.
Pageof 60